Study on rTMS Therapy for Neuropathic Pain in Spinal Cord Injury Patients
The study investigates the efficacy of high-frequency rTMS therapy on neuropathic pain and related outcomes in spinal cord injury patients.
Phase III
Neurology / Pain Management
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Strategic implication
Positive results could lead to increased adoption of rTMS in clinical practice, impacting competitors in the pain management space.
Why it matters
This study on rTMS therapy for neuropathic pain could significantly influence clinical practices and treatment guidelines in pain management for spinal cord injury patients. Positive outcomes may lead to broader adoption of rTMS, affecting competitive dynamics in the pain management sector.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results and any subsequent publications or changes in treatment guidelines related to rTMS.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.